Naloxone and Flagyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naloxone (naloxone hydrochloride) and Flagyl (metronidazole). Common drug interactions include pain in extremity among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Naloxone and Flagyl. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Naloxone?

Naloxone has active ingredients of naloxone hydrochloride. eHealthMe is studying from 6,425 Naloxone users. Check the latest studies of Naloxone.

What is Flagyl?

Flagyl has active ingredients of metronidazole. It is often used in vaginitis bacterial. eHealthMe is studying from 25,897 Flagyl users. Check the latest studies of Flagyl.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

48 people who take Naloxone and Flagyl together, and have interactions are studied.

Naloxone and Flagyl drug interactions.

What are the common drug interactions of Naloxone and Flagyl, by gender? *:

female:

  1. Pain in extremity
  2. Pneumonia
  3. Infection
  4. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  5. Pyrexia (fever)
  6. Abscess (pus)
  7. Anxiety
  8. Chest pain
  9. Deformity (disfigurement)
  10. Intervertebral disc degeneration (spinal disc degeneration)

male:

  1. Anxiety
  2. Pain
  3. Decreased interest
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hyperlipidaemia (presence of excess lipids in the blood)
  6. Intervertebral disc degeneration (spinal disc degeneration)
  7. Osteolysis (dissolution of bone)
  8. Pain in jaw
  9. Rash
  10. Renal failure acute (rapid kidney dysfunction)

What are the common drug interactions of Naloxone and Flagyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Abnormal behaviour
  2. Acidosis (build-up of carbon dioxide in the blood)
  3. Agitation (state of anxiety or nervous excitement)
  4. Aphasia (damage to the parts of the brain that control language)
  5. Apnoea (suspension of external breathing)
  6. Blood pressure increased
  7. Bradycardia (abnormally slow heart action)
  8. Cardiac arrest
  9. Cardiac failure
  10. Cardiogenic shock (inadequate circulation of blood)

10-19:

  1. Device related infection
  2. Hypokalaemia (low potassium)
  3. Pain in extremity
  4. Pneumonia
  5. Pyrexia (fever)
  6. Aspergillosis (an infection caused by a fungus called aspergillus)
  7. Cardiac arrest
  8. Cardiac failure
  9. Corynebacterium infection (infection by corynebacterium (diphtheria))
  10. Hypoxia (low oxygen in tissues)

20-29:

  1. Abscess limb (limb infection)
  2. Cellulitis of male external genital organ (infection of male genitals soft tissue)
  3. Chronic kidney disease
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Orchitis (inflammation of the testes)
  8. Scrotal abscess (pus in scrotum)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Urinary tract infection

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Deformity (disfigurement)
  3. Discomfort
  4. Emotional disorder
  5. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  6. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  7. General physical health deterioration (weak health status)
  8. Hyperkeratosis (thickening of the outer layer of the skin)
  9. Joint contracture (a permanent shortening of a muscle or joint)
  10. Muscle contracture (a permanent shortening of a muscle)

40-49:

  1. Anxiety
  2. Chest pain
  3. Decreased interest
  4. Dehydration (dryness resulting from the removal of water)
  5. Dyspnoea (difficult or laboured respiration)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. General physical health deterioration (weak health status)
  8. Intervertebral disc degeneration (spinal disc degeneration)
  9. Osteolysis (dissolution of bone)
  10. Osteonecrosis of jaw (death of bone of jaw)

50-59:

  1. Blood bilirubin increased
  2. Cardiac disorder
  3. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  4. Chronic kidney disease
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Diabetes mellitus inadequate control
  7. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  8. Dysarthria (speech disorder)
  9. Dystonia (abnormal muscle tone)
  10. Encephalopathy (functioning of the brain is affected by some agent or condition)

60+:

  1. Back pain
  2. Osteosclerosis (an elevation in bone density)
  3. Abscess (pus)
  4. Deformity (disfigurement)
  5. Primary sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone)
  6. Chest pain
  7. Confusional state
  8. Gait disturbance
  9. Anxiety
  10. Ataxia (loss of full control of bodily movements)

What are the existing conditions these people have? *

  1. Pain: 7 people, 14.58%
  2. Septic Shock (shock due to blood infection): 5 people, 10.42%
  3. Thrombocytopenia (decrease of platelets in blood): 4 people, 8.33%
  4. Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 8.33%
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 8.33%
  6. Breast Cancer Metastatic: 4 people, 8.33%
  7. Insomnia (sleeplessness): 3 people, 6.25%
  8. High Blood Pressure: 3 people, 6.25%
  9. Diabetes: 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Naloxone and Flagyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naloxone and Flagyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naloxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flagyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naloxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flagyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naloxone hydrochloride and metronidazole (the active ingredients of Naloxone and Flagyl, respectively), and Naloxone and Flagyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: